UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
First Commonwealth Financial
FCF
$2.01B
| $5.35M | ﹤0.01% |
329,347
+86,379
| +36% | +$1.33M |
2013 Q2
48 quarters
|
|
1677
Vanguard Real Estate ETF
VNQ
$36.2B
| $5.33M | ﹤0.01% |
+59,861
| New | +$5.28M |
2025 Q2
0 quarters
|
|
1678
St. Joe Company
JOE
$3.74B
| $5.31M | ﹤0.01% |
111,411
+23,805
| +27% | +$1.06M |
2013 Q2
48 quarters
|
|
1679
Viasat
VSAT
$8.43B
| $5.31M | ﹤0.01% |
363,615
+111,149
| +44% | +$1.12M |
2013 Q2
48 quarters
|
|
1680
S&T Bancorp
STBA
$1.69B
| $5.31M | ﹤0.01% |
140,292
+35,455
| +34% | +$1.3M |
2014 Q1
45 quarters
|
|
1681
Supernus Pharmaceuticals
SUPN
$2.39B
| $5.29M | ﹤0.01% |
167,692
+59,903
| +56% | +$1.92M |
2015 Q2
40 quarters
|
|
1682
Par Pacific Holdings
PARR
$4.42B
| $5.28M | ﹤0.01% |
199,097
+52,856
| +36% | +$1.01M |
2015 Q4
38 quarters
|
|
1683
Vita Coco
COCO
$3.37B
| $5.28M | ﹤0.01% |
146,156
+36,720
| +34% | +$1.23M |
2023 Q3
7 quarters
|
|
1684
MillerKnoll
MLKN
$1.45B
| $5.24M | ﹤0.01% |
269,959
+72,027
| +36% | +$1.23M |
2013 Q2
48 quarters
|
|
1685
DELISTED
Apellis Pharmaceuticals
APLS
| $5.23M | ﹤0.01% |
301,939
+79,305
| +36% | +$1.47M |
2019 Q2
24 quarters
|
|
1686
Symbotic
SYM
$4.91B
| $5.22M | ﹤0.01% |
134,446
+49,547
| +58% | +$1.3M |
2023 Q3
7 quarters
|
|
1687
Andersons Inc
ANDE
$2.3B
| $5.21M | ﹤0.01% |
141,900
+101,406
| +250% | +$3.71M |
2023 Q1
9 quarters
|
|
1688
Macerich
MAC
$6.29B
| $5.21M | ﹤0.01% |
322,100
-4,275
| -1% | -$65.9K |
2023 Q1
9 quarters
|
|
1689
Legend Biotech
LEGN
$3.76B
| $5.19M | ﹤0.01% |
146,322
+32,867
| +29% | +$1.07M |
2021 Q4
14 quarters
|
|
1690
Alphatec Holdings
ATEC
$1.61B
| $5.19M | ﹤0.01% |
467,754
+201,847
| +76% | +$2.32M |
2020 Q4
18 quarters
|
|
1691
Sylvamo
SLVM
$1.27B
| $5.17M | ﹤0.01% |
103,188
+28,296
| +38% | +$1.59M |
2021 Q4
14 quarters
|
|
1692
Veeco
VECO
$2.85B
| $5.15M | ﹤0.01% |
253,215
+60,397
| +31% | +$1.19M |
2013 Q2
48 quarters
|
|
1693
South Bow Corp
SOBO
$7.1B
| $5.14M | ﹤0.01% |
198,486
-549
| -0.3% | -$14K |
2024 Q4
2 quarters
|
|
1694
Newmark Group
NMRK
$2.08B
| $5.14M | ﹤0.01% |
423,197
+136,894
| +48% | +$1.53M |
2018 Q4
26 quarters
|
|
1695
DELISTED
Everi Holdings
EVRI
| $5.14M | ﹤0.01% |
360,911
+64,835
| +22% | +$907K |
2017 Q4
30 quarters
|
|
1696
DELISTED
Hillenbrand
HI
| $5.08M | ﹤0.01% |
253,347
+64,500
| +34% | +$1.34M |
2013 Q2
48 quarters
|
|
1697
GRAIL Inc
GRAL
$6.23B
| $5.08M | ﹤0.01% |
98,713
+6,248
| +7% | +$226K |
2024 Q2
4 quarters
|
|
1698
Oceaneering
OII
$4.31B
| $5.07M | ﹤0.01% |
244,681
+87,245
| +55% | +$1.68M |
2013 Q2
48 quarters
|
|
1699
Transocean
RIG
$6.24B
| $5.05M | ﹤0.01% |
1,949,741
+680,488
| +54% | +$1.75M |
2013 Q2
48 quarters
|
|
1700
Asana
ASAN
$2.23B
| $5.03M | ﹤0.01% |
372,279
+113,546
| +44% | +$1.78M |
2021 Q2
16 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.